Previous 10 | Next 10 |
IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient Outcomes PR Newswire Innovating as a global leader in cryoablation technologies, with 42 patents issued and allowed Cryogenic flow control enhances th...
IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference PR Newswire CAESAREA, Israel , March 7, 2024 /PRNewswire/ -- ...
IceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024 PR Newswire MRI reveals disappearance of hemorrhagic signal and development of necrotic changes Pain reduced from a median of 7 on...
Fourth BRIIT Conference in India Features IceCure's ProSense® in Breast Cancer Imaging & Interventions Workshop Fourth BRIIT Conference in India Features IceCure's ProSense® in Breast Cancer Imaging & Interventions Workshop PR Newswire Session conducted...
Study Using IceCure's ProSense® Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer PR Newswire Independent study in women deemed inoperable for breast cancer reports median tumor reduction of 100% at 6 and 12 months following cryoablation ...
IceCure's ProSense® to be Featured at Two Upcoming Medical Conferences in Japan PR Newswire CAESAREA, Israel , Feb. 15, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minim...
2024-01-31 08:28:40 ET Losers: Remark Holdings ( MARK ) -46% . Nuvve Holding Corp ( NVVE ) -30% . New York Community Bancorp NYCB -26% after Q4 earnings release . Mmtec ( MTC ) -18% . Extreme Networks EXTR -4% after Q2 earnings rel...
2024-01-30 17:23:08 ET More on IceCure Medical IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript IceCure shares rally 53% on ProSense kidney cancer study IceCure stock climbs 10% amid FDA appeal, earnings report Seeking Alpha’s Quant Rating o...
U.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo Classification Request for Marketing Authorization of ProSense® for Early-Stage Breast Cancer PR Newswire IceCure to submit full 5-year dataset from entire ICE3 study population to the FDA this spring, ahead of p...
IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class PR Newswire IceCure exhibits and provides hands-on demonstrations at SIO 2024 Annual Meeting in Ca...
News, Short Squeeze, Breakout and More Instantly...
IceCure Medical Ltd. Company Name:
ICCM Stock Symbol:
NASDAQ Market:
IceCure Medical to Highlight Key Achievements and Provide Business Overview at A.G.P. / Alliance Global Partners' Virtual Healthcare Company Showcase PR Newswire CAESAREA, Israel , May 20, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or...
The Oncology Institute, Inc. (NASDAQ: TOI) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.12...
Independent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure's ProSense®, Adding to Continued Positive Data Published Globally PR Newswire Study published in the peer reviewed journal Breast Cancer ...